$PHR

Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR

DJS Law Group said it is reminding investors of a securities class action against Phreesia, Inc. (NYSE: PHR) alleging violations of Exchange Act §§10(b) and 20(a) and Rule 10b-5, according to the complaint. The suit covers purchases from May 8, 2025 to March 30, 2026, with a July 13, 2026 deadline.

Original reporting
Published Jun 3, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 6:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefRegulation
Primary signal
$PHR
Bearish
medium confidence
Mentioned
$PHR
Relevance
8/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$PHRBearishLow
01

Why it matters

Potentially increases perceived litigation risk and could widen the equity risk premium for PHR; however, the article does not provide new financial results or a fresh company action beyond the lawsuit reminder.

02

Market read

A negative litigation headline for PHR tied to alleged guidance/misstatement risk during the class period.

03

What to watch

Traders should watch for the actual complaint/filing details, any subsequent SEC/earnings disclosures, and whether the alleged class period overlaps with prior market reactions.

Relevance 8/10Novelty 3/10Timing: pre-market today (press release published June 3, 2026)

Background

The release reminds investors of a class action alleging violations of Exchange Act Sections 10(b) and 20(a) and Rule 10b-5, with a defined class period (May 8, 2025–Mar 30, 2026).

Company-level read

Ticker impact

$PHRBearishMedium confidence
Context

Phreesia (PHR) is named in a securities class action alleging false/misleading statements about marketing commitments and FY2027 guidance reliability.

Expected impact

Near-term downside/volatility risk; magnitude likely limited unless additional filings, motions, or related disclosures emerge.

Evidence & confidence

The article is a law-firm solicitation but specifies alleged misstatements tied to guidance and segment growth, which can affect investor sentiment and risk premium.

Market effects

Adds to litigation/regulatory overhang risk for healthcare/pharma marketing-services firms, but provides no new sector datapoints.

Primarily US-listed small/mid-cap sentiment impact; no specific regional linkage beyond NYSE listing.

Limited—US securities-law framing with no cross-border operational facts.

Counterpoint

As a law-firm press release, it may not reflect new factual developments; the market may already price prior allegations.

Key entities

  • Phreesia, Inc.

    Subject of the securities class action alleging misleading statements about marketing commitments and FY2027 guidance reliability.

  • DJS Law Group

    Law firm soliciting investors to discuss potential lead plaintiff roles; not an issuer-side disclosure.

  • U.S. Securities and Exchange Commission

    Referenced as the basis for alleged violations under federal securities laws.

Related articles

$PHRLowAI 8/10

SueWallSt Reminds Phreesia, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 13, 2026 - PHR

SueWallSt says Phreesia, Inc. (NYSE: PHR) investors in a securities class action filed in Delaware must file a lead-plaintiff motion by July 13, 2026. The article links the case to a March 30, 2026 revenue outlook cut to $510–$520 million from $545–$559 million, after shares fell 27% and investors allegedly lost $3.03/share.

$COINMed

Coinbase stock price today: August 7, 2026

Coinbase (Nasdaq: COIN) closed around $148 on Aug. 7, 2026, near the bottom of its 52-week range, as a crypto downturn weighed on its revenue outlook. A Michigan federal judge rejected Coinbase’s bid to block state enforcement of planned sports event contracts tied to Kalshi, a setback for its prediction-market plans. Coinbase’s results track crypto prices and volumes.

$MRNAMedAI 9/10

FDA Approves New, More Effective Flu Vaccine From Moderna

The FDA approved Moderna’s mRNA flu vaccine, mFlusiva, for adults 50 to 64 and 65 and older, according to Moderna. The company said it is about 27% more effective than standard flu shots, citing roughly 83% effectiveness versus typical 22% to 56%. The article notes CDC data on U.S. flu deaths in 2025.

$METAMedAI 8/10

Meta New Mexico Fine Hits $942 Million in Child Safety Case

A New Mexico court ordered Meta to pay an additional $567 million in a child-safety case, bringing the total fine to about $942 million after a $375 million penalty in March, according to the court. The ruling also requires changes to Facebook and Instagram for users under 18, including limiting Like counts, restricting push notifications overnight, and capping usage at 90 hours per month. Meta said it will appeal.